Latest Industry Insights

Liquid chromatography (LC) is an essential technique is many analytical labs. Dr Bob Pirok and his team use informatics techniques to make LC more automated and pain-free. Technology Networks recently spoke to Pirok to find out more about his innovative algorithms.

Single-cell technologies have positioned themselves at the forefront of biomedical research. But the value of these systems risks being impaired by bottlenecks in data analysis and handling. To find out more, we spoke to Marilyn Matz, CEO and co-founder of Paradigm4.

Genomic data company PetaGene recently sounded a warning that Genome UK, the UK government’s recently announced genomic healthcare strategy, needs to address important data handling challenges to maintain public trust. To find out more, Technology Networks spoke to PetaGene’s co-founder and chief commercial officer, Vaughan Wittorff, PhD, and co-founder and chief executive officer, Dan Greenfield, PhD.

Emerging technologies have the potential to significantly transform the laboratory environment. In this Insight, Labforward's Phoebe Chubb outlines what the lab of the future will look like.

Data integrity is fundamental to drug development and manufacturing but can be difficult to achieve for drug developers and manufacturers who have to navigate strict data integrity guidelines provided by regulatory authorities and find effective ways to attain compliance.

It is an unavoidable fact that high-performance computing (HPC) is an energy-intensive environment. In this Insight, OCF's Mischa van Kesteren investigates the steps we can take to address this and achieve a more sustainable future for HPC.

It’s imperative that scientists and leaders in the COVID-19 vaccine development space have good data management practices to ensure the quality of data and to recue the time-to-market now, and in the future. In this article, we explore how to make data work for you when manufacturing an effective vaccine.

See how cryo-EM advances are changing scientific research, particularly in cell and drug discovery studies, and the role that precision instruments are playing in this.

Clear Labs is a company focused on the latest technologies in molecular testing, machine learning, automation and bioinformatics – it develops fully automated next-generation sequencing and in vitro diagnostics solutions. Technology Networks had the pleasure of speaking with ClearLabs’ CEO Sasan Amini, to learn more about the company’s NGS-based COVID test, Clear Dx™.

For companies in the life sciences and pharma industry, a long-standing challenge is the need to digitize and make available legacy data for drug development workflows. At the same time, they must also incorporate the latest technologies into drug development and testing processes. In this article, Mark Spencer explores how companies can tackle these dual challenges with the help of informatics solutions.